Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 22;22(2):1095-1103.
doi: 10.1007/s40200-023-01186-5. eCollection 2023 Dec.

'Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model'

Esmaeil Mohammadi  1 , Moein Yoosefi  1 , Elaheh Shaker  1 , Elnaz Shahmohamadi  1 , Erfan Ghasemi  1 , Naser Ahmadi  1 , Sina Azadnajafabad  1 , Mohammad-Mahdi Rashidi  1 , Nazila Rezaei  1   2 , Sogol Koolaji  1 , Arezou Dilmaghani-Marand  1   2 , Sahar Mohammadi Fateh  1 , Ameneh Kazemi  1 , Rosa Haghshenas  1 , Negar Rezaei  1
Affiliations

'Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model'

Esmaeil Mohammadi et al. J Diabetes Metab Disord. .

Abstract

Purpose: While many studies have reported hypertension (HTN) and pre-hypertension (PHTN) in large geographic locations of Iran, information regarding district levels is missing. We aimed to examine inequalities in the prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment of adults in districts of Iran.

Methods: We used 27,165 participants' data from the STEPS 2016 study in Iran. A small area estimation model was carried out to predict HTN in the 429 districts of Iran. HTN and PHTN were defined based on the American Heart Association Guideline. Awareness of being hypertensive, treatment coverage, and effective treatment were also estimated.

Results: HTN's crude prevalence was estimated to be in the range of 11.5-42.2% in districts. About PHTN, it was estimated to be 19.9-56.1%. Moreover, for awareness, treatment coverage, and effective treatment crude estimates ranged from 24.3 to 79.9%, 9.1 - 64.6%, and 19.5 - 68.3%, respectively, indicating inequalities in the distribution of aforementioned variables in 429 districts of Iran. Overall, better conditions were detected in central geographical locations and in females.

Conclusion: The inequality of increased blood pressure disorder and related measures are high in districts of Iran and pave the way for policymakers and local health organizers to use the findings of this study to address the inequity of existing resources and improve HTN control.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01186-5.

Keywords: Effective treatment; Epidemiology; Hypertension; STEPS; Small area estimation.

PubMed Disclaimer

Conflict of interest statement

Competing interestAll authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Figures

Fig. 1
Fig. 1
District plots of (A) hypertension, (B) pre-hypertension, (C) awareness of being diseased, (D) anti-hypertensives coverage, and (E) effectiveness of medical interventions
Fig. 2
Fig. 2
Female to male scatter plots of (A) hypertension, (B) pre-hypertension, (C) anti-hypertensives coverage, (D) awareness of being diseased. Each data point represents one district
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6. - PubMed
    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The lancet. 2005;365(9455):217–23. - PubMed
    1. Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569–71. - PubMed
    1. Mensah GA. The global burden of hypertension: good news and bad news. Cardiol Clin. 2002;20(2):181–5. - PubMed
    1. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Cent. 2016;11(4):159. - PMC - PubMed

LinkOut - more resources